A0A2R8Z608 (A0A2R8Z608_PANPA) Pan paniscus (Pygmy chimpanzee) (Bonobo)
Farnesyl pyrophosphate synthase UniProtKBInterProSTRINGInteractive Modelling
419 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: P14324; Pan troglodytes: H2Q079, A0A6D2WRD2; Gorilla gorilla gorilla: G3QDS5
It is possible new templates exist for this target since these models were created.
Available Structures
88 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of human FPPS in complex with YS_04_70 | homo-2-mer | 100 | 2×YS4; 6×MG; | |||
| Crystal structure of human FPPS in complex with magnesium and JDS05120 | homo-2-mer | 100.0 | 2×JD5; 6×MG; | |||
| Crystal structure of human FPPS in ternary complex with YS0470 and inorganic phosphate | homo-2-mer | 100 | 2×YS4; 2×PO4; 6×MG; | |||
| Crystal structure of human FPPS in ternary complex with YS0470 and inorganic pyrophosphate | homo-2-mer | 100 | 2×YS4; 2×POP; 6×MG; | |||
| Crystal structure of human FPPS in ternary complex with YS0470 and isopentenyl pyrophosphate | homo-2-mer | 100 | 2×YS4; 2×IPR; 6×MG; | |||
| Crystal structure of human FPPS in complex with [({5-[4-(propan-2-yloxy)phenyl]pyridin-3-yl}amino)m… | homo-2-mer | 100 | 6×MG; 2×JD1; 2×GOL; | |||
| Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1260 | homo-2-mer | 100 | 2×4GA; 6×MG; 4×PO4; | |||
| Crystal structure of human farnesyl diphosphoate synthase in complex with zoledronate and taxodione | homo-2-mer | 100 | 2×ZOL; 2×1WO; 6×MG; | |||
| Human farnesyl diphosphate synthase in complex with Arenarone and zoledronate | homo-2-mer | 100 | 2×1XH; 2×ZOL; 6×MG; | |||
| Crystal structure of human FPPS in complex with magnesium, CL02134, and inorganic pyrophosphate | homo-2-mer | 100 | 2×YL2; 2×POP; 6×MG; | |||
| Crystal structure of human FPPS in complex with pamidronate | homo-2-mer | 100 | 2×PO4; 6×MN; 2×210; | |||
| Crystal structure of human FPPS in complex with zoledronate and isopentenyl diphosphate | homo-2-mer | 100 | 6×MG; 2×IPE; 2×ZOL; | |||
| Crystal Structure of Human Farnesyl Pyrophosphate Synthase (Y204F) Mutant Complexed with Mg, Risedr… | homo-2-mer | 99.71 | 6×MG; 2×IPE; 2×RIS; | |||
| Crystal Structure of Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg, Risedronate … | homo-2-mer | 99.71 | 6×MG; 2×IPE; 2×RIS; | |||
| Crystal structure of human FPPS in complex with salicylic acid derivative 3a | homo-2-mer | 100 | 4×GOL; 2×5B9; 2×MG; 2×PO4; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | homo-2-mer | 100.0 | 2×YL6; 2×PO4; 4×CL; | |||
| Crystal Structure of Farnesyl Synthase Mutant (Y204A) Complexed with Mg, Alendronate and Isopenteny… | homo-2-mer | 99.71 | 6×MG; 2×IPE; 2×AHD; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-78 | homo-2-mer | 100.0 | 2×GOL; 4×M2V; 2×PO4; | |||
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | homo-2-mer | 99.71 | 6×MG; 2×IPE; 2×RIS; | |||
| Human FPPS complex with FBS_04 and zoledronic acid/MG2+ | homo-2-mer | 100 | 2×3N3; 2×ZOL; 6×MG; 4×PO4; | |||
| Human farnesyl diphosphate synthase complexed with MG and minodronate | homo-2-mer | 100 | 8×MG; 2×M0N; | |||
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | homo-2-mer | 99.41 | 6×MG; 2×210; 2×EDO; 2×PEG; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | homo-2-mer | 100.0 | 2×GOL; 4×YF7; 2×PGE; 2×EDO; 4×CL; 2×PO4; | |||
| Crystal structure of human FPPS in complex with magnesium, JDS05120, and sulfate | homo-2-mer | 100 | 2×JD5; 6×MG; 2×SO4; | |||
| Crystal structure of human FPPS in complex with Zoledronate and Zn2+ | homo-2-mer | 100 | 6×ZN; 2×PO4; 2×ZOL; | |||
| Crystal structure of human FPPS in complex with compound 13 | homo-2-mer | 100 | 2×59Y; | |||
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | homo-2-mer | 99.41 | 6×MG; 2×IPE; 2×210; | |||
| Human FDPS Synthase in Complex with a N-Methyl Pyridinum Bisphosphonate | homo-2-mer | 100.0 | 2×UNR; 6×MG; 2×SO4; | |||
| Crystal structure of human FPPS in complex with alendronate | homo-2-mer | 100 | 6×ZN; 2×PO4; 2×AHD; | |||
| Human FPPS COMPLEX WITH FBS_01 | homo-2-mer | 100 | 4×3N1; 2×PO4; | |||
| Crystal structure of human FPPS in complex with [({4-[4-(cyclopropyloxy)phenyl]pyridin-2-yl}amino)m… | homo-2-mer | 100 | 6×MG; 2×YS1; 2×GOL; | |||
| Human fpps complex with NOV_304 | homo-2-mer | 100 | 4×GO0; 2×PO4; | |||
| Crystal structure of FPPS in complex with Zoledronate | homo-2-mer | 100 | 2×PO4; 6×MG; 2×ZOL; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02-82 | homo-2-mer | 100 | 4×M2Y; 2×PO4; | |||
| Crystal structure of human FPPS in complex with biaryl compound 8e | homo-2-mer | 100 | 2×5BL; | |||
| Human FPPS complex with NOV_980 and zoledronic acid/MG2+ | homo-2-mer | 100 | 2×3N5; 2×ZOL; 6×MG; 2×PO4; | |||
| Human fpps complex with NOV_311 | homo-2-mer | 100 | 4×GO1; 2×PO4; | |||
| Crystal structure of human FPPS in complex with biaryl compound 5 | homo-2-mer | 100 | 2×5BJ; 2×PO4; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-08-038 | homo-2-mer | 100.0 | 4×SO4; 6×YL5; | |||
| Human FPPS COMPLEX WITH NOV_292 | homo-2-mer | 100 | 2×3N4; 2×PO4; | |||
| Human FPPS COMPLEX WITH FBS_02 | homo-2-mer | 100 | 2×3N2; 2×PO4; | |||
| Crystal structure of human FPPS in complex with the monophosphonate compound 15 | homo-2-mer | 100 | 2×5A7; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor AM-02-072 | homo-2-mer | 100.0 | 2×PO4; 4×7AM; | |||
| Human FPPS complex with FBS_03 | homo-2-mer | 100 | 4×MS0; 2×PO4; | |||
| Crystal structure of human FPPS in complex with magnesium, CL01131, and sulfate | homo-2-mer | 100 | 2×1MV; 2×SO4; 6×MG; | |||
| Crystal structure of human FPPS in complex with monophosphonate compound 7 | homo-2-mer | 100 | 2×59Z; 2×PO4; | |||
| Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate | homo-2-mer | 100 | 6×MG; 2×RIS; | |||
| Neutron crystal structure of human farnesyl pyrophosphate synthase in complex with risedronate and … | homo-2-mer | 100 | 6×MG; 2×RIS; 2×IPE; | |||
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | homo-2-mer | 99.11 | 2×RIS; 6×MG; 12×EDO; 2×PO4; | |||
| The effects of Lysine 200 and Phenylalanine 239 Farnesyl Pyrophosphate Synthase (FPPS) mutations on… | homo-2-mer | 99.41 | 6×MG; 2×RIS; 2×IPE; 4×EDO; | |||
| New lower bone affinity bisphosphonate drug design for effective use in diseases characterized by a… | homo-2-mer | 100.0 | 2×39L; 6×MG; | |||
| Crystal structure of human farnesyl pyrophosphate synthase T210S mutant bound to risedronate | homo-2-mer | 99.71 | 6×MG; 2×RIS; | |||
| Crystal structure of human FPPS in complex with nickel, JDS05120, and sulfate | homo-2-mer | 100 | 6×NI; 2×JD5; 2×SO4; | |||
| Crystal structure of human FPPS in complex with ibandronate | homo-2-mer | 100 | 6×ZN; 2×PO4; 2×BFQ; | |||
| Crystal Structure of Farnesyl Pyrophosphate Synthase (Y204A) Mutant complexed with Mg, Pamidronate | homo-2-mer | 99.7 | 2×210; 6×MG; 12×EDO; | |||
| Human FDPS Synthase in Complex with a Rigid Analog of Risedronate | homo-2-mer | 100.0 | 2×UNV; 6×MG; 2×SO4; | |||
| Crystal structure of human farnesyl pyrophosphate synthase (t201a mutant) complexed with mg and zol… | homo-2-mer | 99.7 | 6×MG; 2×ZOL; 2×EDO; | |||
| Crystal structure of human FPPS in complex with YS0470 and two molecules of inorganic phosphate | homo-2-mer | 100 | 2×YS4; 4×PO4; 6×MG; 2×CL; | |||
| Human FDPS synthase in complex with novel inhibitor | homo-2-mer | 100.0 | 2×MG; 2×SO4; 2×11P; | |||
| Human FDPS synthase in complex with minodronate | homo-2-mer | 100.0 | 2×M0N; 6×MG; | |||
| The role of lysine 200 in the human farnesyl pyrophosphate synthase catalytic mechanism and the mod… | homo-2-mer | 99.41 | 6×MG; 2×RIS; 4×EDO; | |||
| Crystal structure of human FPPS in complex with CL03093 | homo-2-mer | 100 | 2×PO4; 2×YL3; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-08-066 | homo-2-mer | 100.0 | 4×SO4; 4×YL6; | |||
| Crystal structure of human FPPS in complex with CL01131 | homo-2-mer | 100.0 | 2×PO4; 2×1MV; | |||
| Crystal Structure of Human Farnesyl Pyrophosphate Synthase Mutant (Y204A) Complexed with Mg and Zol… | homo-2-mer | 99.71 | 6×MG; 2×ZOL; 2×EDO; | |||
| Crystal structure of human FPPS in complex with biaryl compound 6 | homo-2-mer | 100 | 4×GOL; 2×5BK; 2×PO4; | |||
| Crystal structure of human FPPS in complex with WC01088 | homo-2-mer | 100 | 4×PO4; 2×WC1; 2×GOL; | |||
| Crystal structure of human FPPS with allosterically bound FPP | homo-2-mer | 100.0 | 2×PO4; 2×FPP; | |||
| The role of threonine 201 and tyrosine 204 in the human farnesyl pyrophosphate synthase catalytic m… | homo-2-mer | 99.7 | 2×RIS; 6×MG; 2×SO4; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-102 | homo-2-mer | 100.0 | 2×GOL; 2×KFA; 2×PO4; | |||
| Crystal structure of unliganded human FPPS at 2.15 angstrom resolution | homo-2-mer | 100 | 2×PO4; | |||
| Human FPPS complex with NOV_823 | homo-2-mer | 100 | 2×BFH; 2×PO4; | |||
| Crystal Structure of Unliganded Human FPPS | homo-2-mer | 100 | 2×PO4; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor MIT-01-055 | homo-2-mer | 100.0 | 2×PO4; 4×CL; 4×6O3; | |||
| X-ray structure of Farnesyl diphosphate synthase protein | homo-2-mer | 100.0 | 6×MG; 2×IPE; 2×ZOL; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor CL-06-057 | homo-2-mer | 100.0 | 4×CL; 2×YL4; | |||
| Crystal Structure of Human Farnesyl Diphosphate Synthase in Complex with BPH-1222 | homo-2-mer | 100.0 | 4×PO4; 6×MG; 2×N1Z; | |||
| Crystal structure of human FPPS in complex with an allosteric inhibitor YF-02037 | homo-2-mer | 100.0 | 2×GOL; 2×KF7; 2×CL; | |||
| Crystal structure of human FPPS in complex with three magnesium ions | homo-2-mer | 100 | 6×MG; 4×SO4; | |||
| Crystal structure of human farnesyl diphosphate synthase in complex with BPH-1358 | homo-2-mer | 100.0 | 2×3F2; 2×PO4; | |||
| Crystal structure of human FPPS in complex with one magnesium ion | homo-2-mer | 100 | 2×MG; 4×SO4; | |||
| Human farnesyl diphosphate synthase in complex with Taxodione | homo-2-mer | 100.0 | 4×1WO; | |||
| Crystal structure of human farnesyl diphosphate synthase (T201A mutant) complexed with Mg and bipho… | homo-2-mer | 99.7 | 6×MG; 2×RSX; | |||
| Human farnesyl diphosphate synthase complexed with Mg and risedronate | homo-2-mer | 100.0 | 6×MG; 4×PO4; 2×RIS; | |||
| Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-461 | homo-2-mer | 100.0 | 4×PO4; 6×MG; 2×NI9; | |||
| Human Farnesyl Diphosphate Synthase Complexed with Bisphosphonate BPH-527 | homo-2-mer | 100.0 | 6×MG; 4×PO4; 2×SUF; | |||
| Human farnesyl diphosphate synthase complexed with risedronate | homo-2-mer | 100.0 | 6×MG; 4×PO4; 2×RIS; | |||
| Crystal structure of human FPPS in complex with an inhibitor THZ93 | monomer | 100.0 | 2×PO4; 3×MG; 1×T93; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4dem.1.B | homo-2-mer | 0.88 | 2×YS4; 2×MG; | 100.00 | ||